|
| |
ConjunctivalDownload PDF containing detailed information.
Recent Publications on Conjunctival: |  |
Incidence of conjunctival exposure following drainage device implantation in patients with glaucoma.
Purpose. To evaluate prior studies including a glaucoma drainage device... | 21st November, 2009
| PRN Pharmaceutical Research Network, LLC, Dallas, TX - USA.
| Eur J Ophthalmol. 2009 Nov 5.
|
Use of a novel real-time PCR technique to monitor and quantitate Mycoplasma bovis infection in cattle herds with mastitis and respiratory disease.
Mycoplasma bovis infection of cattle tends to persist in affected herds... | 21st November, 2009
| Institute of Molecular Pathogenesis, Friedrich-Loeffler-Institut, Federal
| Vet J. 2009 Nov 17.
DOI Direct Link |
The effects of combination glaucoma medications on ocular surface epithelial cells.
INTRODUCTION: The purpose of this study was to determine the effects of... | 19th November, 2009
| Rocky Mountain Lions Eye Institute, Department of Ophthalmology,
| Adv Ther. 2009 Nov 18.
DOI Direct Link |
[Rehabilitation of patients with burn injury to the eye]
Based on the analysis of the results of treatment in patients with severe... | 18th November, 2009
|
| Vestn Oftalmol. 2009 Sep-Oct;125(5):52-7.
|
Detection of Chlamydophila caviae and Streptococcus equi subsp. zooepidemicus in horses with signs of rhinitis and conjunctivitis.
At a stud farm of Trakehner horses, all 33 foals of a birth cohort... | 17th November, 2009
| State Institute for Consumer Protection of Saxony-Anhalt, Dept. for
| Vet Microbiol. 2009 Oct 23.
DOI Direct Link |
→View more research publications. |
Press Releases About Conjunctival:
|
 |
| ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) |
9th November, 2009 |
ISTA Pharmaceuticals, Inc. |
MIAMI, Nov. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced additional results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5
|
| ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting |
21st October, 2009 |
ISTA Pharmaceuticals, Inc. |
ANAHEIM, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate
|
| ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting |
7th May, 2009 |
ISTA Pharmaceuticals, Inc. |
FT. LAUDERDALE, Fla., May 7 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today presented results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution)
|
| Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis |
4th May, 2009 |
Fovea Pharmaceuticals |
PARIS, May 4 /PRNewswire/ -- Fovea Pharmaceuticals announced today positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients
|
BioPortfolio Ltd. offers e-mail and postal lists for Conjunctival scientists - we have details of around 1259 individuals working on Conjunctival .
This page has been viewed 393 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Conjunctival across BioPortfolio, or for Conjunctival Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
